Health Education England London and South East Pharmacy Business Plan 2022-2023
The Health Education England (HEE) London and South East Pharmacy Business Plan for 2022-2023 outlines the strategic direction for pharmacy education and training across the region. This comprehensive plan addresses the evolving landscape of pharmaceutical services, patient care, and workforce development in the wake of recent challenges in healthcare delivery.
As part of Health Education England's broader mandate to ensure a well-trained healthcare workforce, this pharmacy-specific plan focuses on enhancing the skills, capabilities, and deployment of pharmacy professionals at all levels. The plan aligns with national healthcare priorities while addressing the unique needs of the diverse population served across London and the South East region.
This year's plan places particular emphasis on post-pandemic recovery, digital transformation, and the expanded clinical role of pharmacists in integrated care models. It responds to national initiatives including the Additional Roles Reimbursement Scheme and the expanding independent prescribing capabilities of pharmacists.
The 2022-2023 business plan for pharmacy education and training in the London and South East region centers around five strategic priorities:
These priorities reflect the changing landscape of pharmacy practice and the healthcare environment more broadly. They recognize the increasing clinical responsibilities of pharmacists, the importance of leadership at all levels of the profession, and the need to adapt to digital innovations in healthcare delivery.
The business plan details several key initiatives designed to deliver on the strategic priorities:
A comprehensive independent prescribing training program will be scaled up across the region to meet the growing demand for pharmacist prescribers. The initiative includes:
Recognizing the evolving role of pharmacy technicians, a comprehensive development program will be implemented:
To support the integration of pharmacy professionals within primary care networks:
An expanded focus on digital capabilities will include:
The plan outlines a comprehensive approach to developing the pharmacy workforce across the region:
Addressing workforce challenges through:
Strengthening the education infrastructure through:
Creating clear career progression options through:
The business plan includes a robust framework for measuring the impact of initiatives and ensuring accountability. Key performance indicators will track progress across all strategic priorities:
Regular evaluation activities will include surveys of learners and educators, analysis of workforce data, and assessment of service improvements linked to training initiatives. This feedback will inform continuous improvement of education programs and strategic direction.
Successful implementation of this business plan requires collaboration across multiple stakeholders:
An implementation steering group comprising representatives from these key stakeholder groups will oversee progress and address challenges. Regional implementation leads will coordinate activities within specific geographic areas to ensure cohesive approach while recognizing local needs.
The Health Education England London and South East Pharmacy Business Plan 2022-2023 represents a strategic and comprehensive approach to developing the pharmacy workforce. By focusing on clinical capabilities, leadership, digital skills, and integration within multidisciplinary teams, the plan aims to ensure pharmacy professionals can meet the evolving healthcare needs of the region's population.
Successful implementation of this plan will require collaborative working between Health Education England, healthcare providers, educational institutions, and professional bodies. Through these partnerships and the initiatives outlined in the business plan, the pharmacy workforce will be well-positioned to contribute significantly to improved patient outcomes and more efficient, integrated healthcare delivery across London and the South East.
Regular review and adaptation of the plan based on evaluation of outcomes and changing healthcare landscape will ensure its continued relevance and impact throughout the 2022-2032 period and beyond.
